Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.
about
Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosisNon-alcoholic fatty liver disease: a practical approach to diagnosis and stagingThe Flexibility of Ectopic LipidsHepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations.Accuracy of computer-aided ultrasound as compared with magnetic resonance imaging in the evaluation of nonalcoholic fatty liver disease in obese and eutrophic adolescents.Non-invasive methods for the diagnosis of nonalcoholic fatty liver diseaseRadiologic evaluation of nonalcoholic fatty liver diseaseNon-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy.Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysisStandardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement methodSerial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS study3.0 T proton magnetic resonance spectroscopy of the liver: quantification of cholineHuman immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy.Two- versus three-dimensional dual gradient-echo MRI of the liver: a technical comparison.Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurementDiagnostic performance of a rapid magnetic resonance imaging method of measuring hepatic steatosis.Feasibility and reproducibility of echo planar spectroscopic imaging on the quantification of hepatic fat.TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.Normal range of hepatic fat fraction on dual- and triple-echo fat quantification MR in children.T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease.Ectopic fat accumulation and distant organ-specific insulin resistance in Japanese people with nonalcoholic fatty liver disease.Gadoxetate acid-enhanced MRI of hepatocellular carcinoma in a c-myc/TGFα transgenic mouse model including signal intensity and fat content: initial experience.Role of quantification of hepatic steatosis and future remnant volume in predicting hepatic dysfunction and complications after liver resection for colorectal metastases: a pilot studyVitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng StudyStereological Analysis of Liver Biopsy Histology Sections as a Reference Standard for Validating Non-Invasive Liver Fat Fraction Measurements by MRIEffect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial.Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosisCorrelation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLDMagnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosisComparisons of parallel potential biomarkers of 1H-MRS-measured hepatic lipid content in patients with non-alcoholic fatty liver disease.Quantification of liver fat with magnetic resonance imaging.ASH and NASH.Liver-vessel cancellation artifact on in-phase and out-of-phase MRI imaging: a sign of ultra-high liver fat content.Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis.Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.
P2860
Q26858875-3D8659BA-4DAB-4DFE-A7D0-C8F1FF2477E8Q27006131-373343AB-EAE4-4D9F-97D1-F26C88DBC476Q28076063-CBB459A1-6489-40AE-A878-AF1AF7C8FC37Q30395051-CFED96C1-2511-42D7-8897-DCBDC4764391Q30403032-A67DA86C-4813-4CB2-B6A4-393099A8F703Q30414504-31AA0C6F-771D-40FC-88CD-79DE9324F03AQ30436162-5EAFE60F-7D6C-471A-8FFE-F9DC0514B128Q30441653-0B7A5443-1B3B-4DDD-A23E-3119DE753EE8Q30445138-191CC2D8-7DDB-4BF8-BCDA-8CE5B979719CQ30497534-A1B2954D-B3EC-464A-9D7E-31AD52281CA2Q30504580-872E9FD1-EDD8-4953-9C10-8EF76EB4A1A5Q30563967-2C41E1B8-6509-41C2-A175-BD357B85DE21Q30608766-75FFE14F-5445-4266-9E80-D487A3FC5D41Q31149395-2AEBE476-A168-48C0-845F-4B7978401C26Q31155800-AEB73E00-FD38-4278-9C84-023B571EE7E8Q34021973-BC3793C9-8E2E-46A6-ABC5-498B002E4F38Q34366849-AEB88D25-0C68-409D-BF5A-5AAE472C349FQ34612486-C837E241-E632-4C32-A131-5D4BF6016DD4Q34651049-E7254AA3-B6D7-4B47-8498-E664BE862514Q34712845-3353C913-001F-45B2-9E4C-A0E381AF765BQ34785862-F36A3A0D-C985-4960-89D1-2A0AB9CCC7D2Q35057832-F790C4E9-D351-4428-A0FF-54D5F9D4656AQ35093622-55FB9318-023B-4D6D-9A18-0F1D3B2E010FQ35126355-EF983905-13AD-4283-94CF-7C07E207E28FQ35909487-FA0BB5BA-3999-4073-9643-27FFDEBF44E1Q36020112-D11F0746-F633-44B0-AF84-0B20DDB82D53Q36047914-2352DB79-89F2-4502-9DFA-35DD5CE7A916Q36097591-344D378B-99BB-4A65-8E3C-A87C5340701EQ36105168-19F9E71D-5544-466D-A99C-2AB5328FCB51Q36174863-CA6D61AA-3925-4474-9C4B-591413B91140Q36219404-8690FBF2-5174-4674-B130-833BACA3B699Q36348762-62FB7143-B855-4711-9B75-859912C007F4Q36785616-17357B45-C059-47BA-B244-EE41DFC7F255Q36799486-3987FEAB-9122-4279-A3D2-094BA1CC0F20Q37811338-8F97A104-7E95-4E50-BA61-4FB1A94B66E3Q37898415-5F514DF0-ED59-44E7-8979-D9053FF5459EQ37968566-DF08B7DA-D7D1-42E2-A31B-641BE27FFD4AQ37978790-A2968696-7A43-4130-9031-50B2F976D905Q38128548-984CAB9E-E937-44F4-B2FA-CBA5BE2D61D7Q38204970-B268F577-38D2-42B2-B1B9-D50623717312
P2860
Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Magnetic resonance imaging and ...... age of fibrosis is considered.
@en
Magnetic resonance imaging and ...... age of fibrosis is considered.
@nl
type
label
Magnetic resonance imaging and ...... age of fibrosis is considered.
@en
Magnetic resonance imaging and ...... age of fibrosis is considered.
@nl
prefLabel
Magnetic resonance imaging and ...... age of fibrosis is considered.
@en
Magnetic resonance imaging and ...... age of fibrosis is considered.
@nl
P2093
P50
P1476
Magnetic resonance imaging and ...... tage of fibrosis is considered
@en
P2093
Andrew Volp
Dinesh Jothimani
Jonathan Fawcett
Julie R Jonsson
Leigh Horsfall
Mark Benson
Peter O'Rourke
P304
P356
10.1016/J.JHEP.2009.04.012
P577
2009-05-18T00:00:00Z